Clinical Trial Update: Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase trial evaluated whether applying human amniotic membrane can reduce postoperative atrial fibrillation, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Human Amniotic Membrane (human amniotic membrane)

Snippet

Sponsor: University of Utah | Conditions: Atrial Fibrillation | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-12-06